Abacus Health Products, Inc. Launches New Advanced Skincare and Treatment Line

Published: February 7, 2019

Abacus Health Products, Inc. Launches New Advanced Skincare and Treatment Line

Abacus Health Products, Inc. launched its advanced skincare line within its CBDMEDIC™ family of products for the treatment of acne, eczema, and itch and rash. This new line will include four topical products, including ointments, creams and facial cleansers, utilizing FDA-monograph active pharmaceutical ingredients, cannabinoids, and formulated with natural and organic ingredients. According to a report from Grand View Research, the market for acne treatment was estimated to be US$1.4 billion in 2018, while eczema is one of the most common skin conditions affecting more than 30 million Americans.

“We are tremendously proud to introduce the latest skincare products in our line of innovative topical treatments,” said Perry Antelman, CEO of Abacus. “Our market leadership in the commercialization of over-the-counter (OTC) products blended with cannabinoids and natural and organic ingredients is a testament to over a decade of research, our pharmaceutical heritage and formulation expertise.”

Abacus continues to focus on establishing strong relationships with retail pharmacy and mass and grocery store markets to support distribution and sales. The Company expects to start selling through these channels in 2019, with the retail pharmacy channel being a key distribution channel and driver of sales.